Answers are grounded in this paper and cite their sources.
Congenital tuberculosis is an uncommon but clinically severe manifestation of Mycobacterium tuberculosis infection that remains challenging to diagnose because of its nonspecific neonatal presentation and delayed maternal diagnosis. This narrative review examines current evidence on epidemiology, clinical presentation, treatment and prevention, with particular emphasis on maternal disease, the maternal–fetal interface, and mechanisms underlying vertical transmission; as an original component, we also performed a case-level curation of published maternal and congenital tuberculosis reports to characterize their geographic distribution. Fetal exposure is more likely in active maternal tuberculosis, particularly when disease is disseminated, extrapulmonary, or genital, with additional risk associated with delayed diagnosis, inadequate treatment, drug resistance, and comorbidities. Vertical transmission may occur through transplacental hematogenous dissemination, aspiration or ingestion of infected amniotic fluid, or exposure to infected genital secretions during delivery. Experimental evidence supports the biological plausibility of placental infection and persistence, although direct mechanistic evidence remains limited. Diagnosis requires integration of maternal history, neonatal findings, microbiological or molecular testing, imaging, and placental examination when available. Early maternal diagnosis and appropriate treatment remain the most effective preventive strategies. Future research should prioritize multicenter prospective cohorts, standardized maternal-neonatal follow-up, and physiologically relevant human models to clarify transmission mechanisms and identify biomarkers of risk.
No takes yet. Share an insight, caveat, or question.
Fonseca-Pérez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: